Next Article in Journal / Special Issue
Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
Previous Article in Journal
Role of Cereal Secondary Metabolites Involved in Mediating the Outcome of Plant-Pathogen Interactions
Previous Article in Special Issue
Accurate Quantification of Lipid Species by Electrospray Ionization Mass Spectrometry — Meets a Key Challenge in Lipidomics
Metabolites 2012, 2(1), 1-18; doi:10.3390/metabo2010001

Perturbations of Lipid Metabolism Indexed by Lipidomic Biomarkers

1,3,*  and 2
1 INSERM U1057, Faculte de Medicine, “P. et M. Curie” 27 rue Chaligny, Paris 75012, France 2 Department of Biochemistry, King’s College London, 150 Stamford Street, London SE1 9NH, UK 3 Laboratory of Mass Spectrometry, Applied Lipid Investigation (APLIPID®), Paris 75012, France
* Author to whom correspondence should be addressed.
Received: 28 November 2011 / Revised: 21 December 2011 / Accepted: 22 December 2011 / Published: 4 January 2012
(This article belongs to the Special Issue Lipidomics)
View Full-Text   |   Download PDF [509 KB, uploaded 4 January 2012]   |  


The lipidome of the liver and the secreted circulating lipoproteins can now be interrogated conveniently by automated mass spectrometric methods. Multivariate analysis of the liver and serum lipid composition in various animal modes or in human patients has pointed to specific molecular species markers. The perturbations of lipid metabolism can be categorized on the basis of three basic pathological mechanisms: (1) an accelerated rate of de novo lipogenesis; (2) perturbation of the peroxisome pathway of ether-lipid and very-long-chain fatty acid biosynthesis; (3) a change in the rate of interconversion of essential omega-3 and -6 polyunsaturated fatty acids. This review provides examples to illustrate the practicalities of lipidomic studies in biomedicine.
Keywords: biomedical lipidomics; pharmacology; biomarkers biomedical lipidomics; pharmacology; biomarkers
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Lamaziere, A.; Wolf, C.; Quinn, P.J. Perturbations of Lipid Metabolism Indexed by Lipidomic Biomarkers. Metabolites 2012, 2, 1-18.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert